UPPER TRACT UROTHELIAL CARCINOMA: MORPHOLOGY, DIAGNOSTICS AND TREATMENT
https://doi.org/10.24835/1607-0763-2018-1-78-92
Abstract
Urothelial carcinoma is a malignant tumor that develops from the cells of the urothelium mucosa and can be detected both in the upper parts of the urinary tract (renal and pelvic system and ureter) and in the lower parts (bladder and urethra). Urothelial cancer of the upper urinary tract (UCUUT) is quite rare and accounts for 5–10% of all cases of urothelial cancer. UCUUT remains completely unexplored, having to date two equal theories of origin. Despite the modern radiology and endoscopic equipment, in view of the meager and sufficiently generalized clinical manifestations (similar to other diseases), especially at the initial stages of the disease, it is necessary to constantly improve diagnostic methods for detecting the disease as early as possible. Already today, thanks to new technologies for diagnosis and treatment, it is possible to identify the disease at different stages and extend life to patients with UCUUT. The article presents data on morphology, clinic, diagnostics and modern methods of treatment of this pathology.
About the Authors
Yu. A. StepanovaRussian Federation
Yulia A. Stepanova – doct. of med. sci., the senior research of radiology methods of diagnostics and treatment department of A.V. Vishnevsky IS; professor of radiology department of IPE of I.M. Sechenov First MSMU.
117997 Moscow, Bol. Serpukhovskaya str., 27, +7-499-236-44-14
A. V. Prokofieva
Russian Federation
Anastasiya V. Prokofieva – Ph-student of radiology department of IPE of I.M. Sechenov First MSMU.
Moscow
S. A. Dunaev
Russian Federation
Saikhan A. Dunaev – assistant of the Faculty Surgery Department.
Grozny
A. V. Glotov
Russian Federation
Andrey V. Glotov – the junior researcher of Patological Anatomy Department.
Moscow
M. V. Morozovz
Russian Federation
Mariya V. Morozova – graduate student of radiology department.
Moscow
A. A. Gritskevich
Russian Federation
Aleksandr A. Gritskevich – cand. of med. sci, the senior research of the Urology department.
Moscow
А. А. Teplov
Russian Federation
Aleksandr A. Teplov – doct. of med. sci., professor, Deputy Director.
Moscow
References
1. Mukamel E., Simon D., Edelman A., Konichezky M., Hadar H., Servadio C. Metachronous bladder tumors in patients with upper urinary tract transitional cell carcinoma. J. Surg. Oncol. 1994; 57: 187–190.
2. Munoz J.J., Ellison L.M. Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J. Urol. 2000; 164: 1523–1525.
3. Zigeuner R.E., Hutterer G., Chromecki T., Rehak P., Langner С. Bladder tumour Development after urothelial carcinoma of the upper urinary tract is related to primary tumour location. BJU Int. 2006; 98: 1181–1186. DOI: 10.1111/j.1464-410X.2006.06519.x.
4. Ploeg M., Aben K.K., Kiemeney L.A. The presentand future burden of urinary bladder cancer in the world. Wld J. Urol. 2009; 27: 289–293. DOI: 10.1007/s00345-009-0383-3.
5. Petkovic S., Mutavdzic M., Petronic V.L., Markovic V. Tumors of the renal pelvis and ureter: clinical and etiologic studies. J. Urol. Nephrol. 1971; 77: 429.
6. Roupret M., Zigeuner R., Palou J., Boehle A., Kaasinen E., Sylvester R., Babjuk M., Oosterlinck W. Tumors of the upper urinary tract: Trans. Chernyaev V.A., scien. ed. Ivanov S.A. M.: European Association of Urology, 2011. 18 p. (In Russian)
7. Fang D., Li X.-S., Xiong G.-Y., Yao L., He Z.-S., Zhou L.-Q. Prophylactic Intravesical Chemotherapy to Prevent Bladder Tumors after Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinomas: A Systematic Review and Meta-Analysis. Urol. Int. 2013; 91: 291–296. DOI: 10.1016/j.jfma.2013.11.004.
8. Volkova M.I., Matveev V.B., Medvedev S.V., Nosov D.A., Khmelevsky E.V., Chernyaev V.A. Clinical recommendations for the diagnosis and treatment of patients with tumors of the upper urinary tract. Moscow: Association of Oncologists of Russia, 2014. 15 p. (In Russian)
9. Yuan H., Chen X., Liu L., Yang L., Pu C., Li J., Bai Y., Han P., Wei Q. Risk factors for intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma: A meta-analysis. Urologic Oncology: Sem. Original Invest. 2014; 32: 989–1002 DOI: 10.1007/s11255-017-1510-5.
10. Rouprêt М., Babjuk M., Compérat E., Zigeuner R., Sylvester R., Burger M., Cowan N., Böhle A., VanRhijn B.W.G., Kaasinen E., Palou J., Shariat S.F. Recomendate for tumors of the upper urinary tract. Scien. ed. Gazimiev M.A. M.: European Association of Urology, 2014. 20 p. (In Russian)
11. Yuan H., Mao X., Bai Y., Li H., Liu L., Pu C., Li J., Tang Y., Wei Q., Han P. The effect of intravesical chemotherapy in the prevention of intravesical recurrence after nephroureterectomy for upper tract urothelial carcinoma: a metaanalysis. J. Chemother. 2015; 27 (4): 195–200. DOI: 10.1179/1973947815Y.0000000034.
12. Kuss R., Chatelain С. Surgery of the ureter. Berlin; Heidelberg; New York: Springer-Verlag, 1975. 338 p. DOI: 10.1007/978-3-642-66079-5.
13. Birarelli B., Morbiducci G. Clinico-radiologic contribution to the study of primary neoplasms of the ureter. Arch. Ital. Urol. 1963; 36: 3–50.
14. Figurin K.M. Malignant neoplasms of renal pelvis and ureter. Oncourologiy. 2006; 2: 5–12. (In Russian)
15. Pyotel A.Ya. I Congress of urologists of Yugoslavia. Urologiya i nephrologiya. 1965; 2: 77–81. (In Russian)
16. Lughezzani G., Sun M., Perrotte P., Shariat S.F., Jeldres C., Budäus L., Latour M., Widmer H., Duclos A., Bénard F., McCormack M., Montorsi F., Karakiewicz P.I. Genderrelated differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database. Urology. 2010; 75 (2): 321–327. DOI: 10.1016/j.urology.2009.09.048.
17. Grollman A.P., Shibutani S., Moriya M., Miller F., Wu L., Moll U., Suzuki N., Fernandes A., Rosenquist T., Medverec Z., Jakovina K., Brdar B., Slade N., Turesky R.J., Goodenough A.K., Rieger R., Vukelić M., Jelaković B. Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proc. Natl. Acad. Sci. USA. 2007; 104 (29): 12129–12134. DOI: 10.1073/pnas.0701248104.
18. Colin P., Koenig P., Ouzzane A., Berthon N., Villers A., Biserte J., Rouprêt M. Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract. BJU Int. 2009; 104 (10): 1436–1440. DOI: 10.1111/j.1464-410X.2009.08838.x.
19. Chen C.H., Dickman K.G., Moriya M., Zavadil J., Sidorenko V.S., Edwards K.L., Gnatenko D.V., Wu L., Turesky R.J., Wu X.-R., Pu Y.-S., Grollman A.P. Aristolochic acid-associated urothelial cancer in Taiwan. Proc. Natl. Acad. Sci. USA. 2012; 109 (21): 8241–8246. DOI: 10.1073/pnas.1119920109.
20. Nephrology. Practical guidance. Ed. I.E. Tareev. Ed. 2nd., processed and add. M.: Medicine, 2000. 688 p. (in Russian)
21. Sernyak P.S., Frolov A.S. Diagnosis and surgical treatment of ureteral tumors. Newspaper “News of Medicine and Pharmacy”. 2009; 20 (300): http://www.mif-ua.com/ archive/article/10885. (In Russian)
22. Moch H., Humphrey P.A., Ulbright T.M., Reuter V. WHO Classification of Tumours of the Urinary System and Male Genital Organs. Fourth ed. Lyon, France: International Agency For Research on Cancer, 2016. 400 p.
23. Seisen T., Granger B., Colin P., Léon P., Utard G., RenardPenna R., Compérat E., Mozer P., Cussenot O., Shariat S.F., Rouprêt M. A Systematic Review and Meta-analysis of Clinicopathologic Factors Linked to Intravesical Recur rence After Radical Nephroureterectomy to Treat Upper Tract Urothelial Carcinoma. Eur Urol. 2015; 67 (6): 1122–1133. DOI: 10.1016/j.eururo.2014.11.035.
24. Habuchi T. Origin of multifocal carcinomas of the bladder and upper urinary tract: molecular analysis and clinical implications. Int. J. Urol. 2005.; 12 (8): 709–716. DOI: 10.1111/j.1442-2042.2005.01155.x.
25. Cheng L., Cheville J.C., Neumann R.M., Bostwick D.G. Natural history of urothelial dysplasia of the bladder. Am. J. Surg. Pathol. 1999; 23: 443–447.
26. Takahashi T., Habuchi T., Kakehi Y., Okuno H., Terachi T., Kato T., Ogawa O. Molecular diagnosis of metastatic origin in a patient with metachronous multiple cancers of the renal pelvis and bladder. Urology. 2000; 56 (2): 331.
27. Vriesema J.L., Aben K.K., Witjes J.A., Kiemeney L.A., Schalken J.A. Superficial and metachronous invasive bladder carcinomas are clonally related. Int. J. Cancer. 2001; 93: 699–702.
28. Matsui Y., Utsunomiya N., Ichioka K., Ueda N., Yoshimura K., Terai A., Arai Y. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract. Urology. 2005; 65: 279–283. DOI: 10.1016/j.urology.2004.09.021.
29. De Torres Mateos J.A., Banus Gassol J.M., Palou Redorta J., Morote Robles J. Vesicorenal reflux and upper urinary tract transitional cell carcinoma after transurethral resection of recurrent superficial bladder carcinoma. J. Urol. 1987; 138 (1): 49–51.
30. Sidransky D., Frost P., Von Eschenbach A., Oyasu R., Preisinger A.C., Vogelstein B. Clonal origin bladder cancer. N. Engl. J. Med. 1992; 326: 737–740.
31. Lunec J., Challen C., Wright C., Mellon K., Neal D.E. C-erbB-2 amplification and identical p53 mutations in concomitant transitional carcinomas of renal pelvis and urinary bladder. Lancet. 1992; 339: 439–440. DOI: 10.1016/0140-6736(92)90135-P.
32. Fujimoto K., Yamada Y., Okajima E., Kakizoe T., Sasaki H., Sugimura T., Terada M. Frequent association of p53 gene mutation in invasive bladder cancer. Cancer Res. 1992; 52: 1393–1308.
33. Steiner G., Schoenberg M.P., Linn J.F., Mao L., Sidr ansky D. Detection of bladder cancer recurrence by microsatellite analysis of urine. Nat. Med. 1997; 3: 621–624.
34. Takahashi T., Habuchi T., Kakehi Y., Mitsumori K., Akao T., Terachi T., Yoshida O. Clonal and chronological genetic analysis of multifocal cancers of the bladder and upper urinary tract. Cancer Res. 1998; 58: 5835–5841.
35. Pereverzev A.S. Surgery of tumors of the kidney and upper urinary tract. Kharkov: Lora Medpharm, 1997. 392 p. (In Russian)
36. Mebel M. Tumors of the renal pelvis and ureter. In: Clinical urology. Ed. E.B. Marinbach. M.: Medicine, 1975: 57–66. (In Russian)
37. Johnson D.E., Babaian R.J. Conservative surgical management for non-invasive distal ureteral carcinoma. Urology. 1979; 13 (4): 365–367.
38. Catalona W.J. Urothelial tumours of the urinary tract. In: Walsh P.C., Retik A.B., Stamey T.A., Vaughan E.D. Jr., eds. Campbell’s Urology. 6th ed. Philadelphia, Pa, USA: W.B. Saunders. 1992. 1094 p.
39. Novara G., De Marco V., Dalpiaz O., Gottardo F., Bouygues V., Galfano A., Martignoni G., Patard J.J., Artibani W., Ficarra V. Independent predictors of metachronous bladder transitional cell carcinoma (TCC) after nephrou reterectomy for TCC of the upper urinary tract. BJU Int. 2008; 101: 1368–1374. DOI: 10.1111/j.1464-410X.2008.07438.x.
40. Gray Sears C.L., Ward J.F., Sears S.T., Puckett M.F, Kane C.J., Amling C.L. Prospective comparison of computerized tomography and excretory urography in the initial evaluation of asymptomatic microhematuria. J. Urol. 2002; 168: 2457–2460.
41. Joffe S.A., Servaes S., Okon S., Horowitz M.. Multi– detector row CT urography in the evaluation of hematuria. RadioGraphics. 2003; 23: 1441–1455.
42. Kim J.K., Cho K.S. CT urography and virtual endoscopy: promising imaging modalities for urinary tract evaluation. Br. J. Radiol. 2003; 76: 199–209.
43. Browne R.F.J., Meehan C.P., Colville J., Power R., Torreggiani W. Transitional Cell Carcinoma of the Upper Urinary Tract: Spectrum of Imaging Findings. RadioGraphics. 2005; 25 (6): 1609–1627. DOI: 10.1148/rg.256045517.
44. Kirkali Z., Tuzel E. Transitional cell carcinoma of the ureter and renal pelvis. Crit. Rev. Oncol. Hematol. 2003; 47: 155–169.
45. Wong-You-Cheong J.J., Wagner B.J., Davis C.J.Jr. Transitional cell carcinoma of the urinary tract: radiologicpathologic correlation. RadioGraphics. 1998; 18: 123–142.
46. Jung P., Brauers A., Nolte-Ernsting C.A., Jakse G., Gunther R.W. Magnetic resonance urography enhanced by gadolinium and diuretics: a comparison with conventional urography in diagnosing the cause of ureteric obstruction. BJU Int. 2000; 86: 960–965.
47. Ignashin N.S., Perepechin D.V. Ultrasonic diagnosis of renal pelvis cancer. Theses of the VII Congress of the Russian Association of Specialists in Ultrasound Diagnostics in Medicine. Moscow, November 10–13, 2015; Part I: 68. (In Russian)
48. Ignashin N.S., Perepechin D.V. Noninvasive ultrasound diagnosis of ureteral cancer. Theses of the VII Congress of the Russian Association of Specialists in Ultrasound Diagnostics in Medicine. Moscow, November 10–13, 2015; Part I: 67–68. (In Russian)
49. Devyatovskaya A.G. Differential ultrasound diagnosis of the causes of unilateral obstruction of the upper urinary tract: Theses of the VII Congress of the Russian Association of Specialists in Ultrasound Diagnostics in Medicine. Moscow, November 10–13, 2015; Part I: 50. (In Russian)
50. Amosov A.V., Krupinov G.E. Ultrasonic methods of functional diagnostics in urological practice. SonoAce International. 2000; 7: 26–30. (In Russian)
51. Zubarev A.V., Gajonova V.E. Diagnostic ultrasound. Uronefrologiya. M.: Real Times, 2002. 248 p. (In Russian)
52. Puech P., Rouprêt M., Renard-Penna R., Lemaître L., Colin P. Imaging of urothelial carcinomas of the upper ract: state of the art review for the yearly scientific report of the National French Association of Urology. Prog Urol. 2014; 4 (15): 987–999. DOI: 10.1016/j.purol.2014.07.009.
53. Aragon-Ching J.B. Challenges and advances in the diagnosis, biology, and treatment of urothelial upper tract and bladder carcinomas. Urol. Oncol. 2017; 35 (7): 462– 464. DOI: 10.1016/j.urolonc.2017.05.023.
54. Gray Sears C.L., Ward J.F., Sears S.T., Puckett M.F, Kane C.J., Amling C.L. Prospective comparison of computerized tomography and excretory urography in the initial evaluation of asymptomatic microhematuria. J. Urol. 2002; 168: 2457–2460.
55. Radiation diagnostics: a textbook. Ed. G.E. Trufanov. In 2 vol. Moscow: GEOTAR-Media, 2011; V. 1. 416 p. (In Russian)
56. Ishchenko K.B. Epidemiology, clinic and diagnostics of urothelial tumors of the renal pelvis and ureter: current state of the problem. Zlokachestvennie opukholi. 2016; 2 (18): 66–71. DOI: 10.18027/2224-5057-2016-2-66-71. (In Russian)
57. Khan A.N. Transitional Cell Carcinoma Imaging. Medscape. 2016; Aug 21. https://emedicine.medscape.com/article/381323-overview#a4
58. Kaza R.K., Ananthakrishnan L., Kambadakone A., Platt J.F. Update of Dual-Energy CT Applications in the Genitourinary Tract. Am. J. Roentgenol. 2017; 208: 1185–1192. DOI: 10.2214/AJR.16.17742.
59. Khalikov A.D., Makovsky A.I. The technique of magnetic resonance urography. Luchevaya diagnostika i therapiya. 2014; 3 (5): 98–102. (In Russian)
60. Ternovoy S.K., Alyaev Yu.G., Sinitsyn V.Е. and others. Diagnostic capabilities and clinical use of MR-urography. Medical Visualization. 2001; 2: 72–77. (In Russian)
61. Lopatkin N.A., Martov A.G., Ergakov D.V. Endoscopic methods of diagnosis and treatment of papillary tumors of the upper urinary tract. Urologiya. 2001; 3: 46–51. (In Russian)
62. Seisen T., Peyronnet B., Dominguez-Escrig J.L., Bruins H.M., Yuan C.Y., Babjuk M., Böhle A., Burger M., Compérat E.M., Cowan N.C., Kaasinen E., Palou J., van Rhijn B.W., Sylvester R.J., Zigeuner R., Shariat S.F., Rouprêt M. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephrourecterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel. Eur Urol. 2016; 70 (6): 1052–1068. DOI: 10.1016/j.eururo.2016.07.01.
Review
For citations:
Stepanova Yu.A., Prokofieva A.V., Dunaev S.A., Glotov A.V., Morozovz M.V., Gritskevich A.A., Teplov А.А. UPPER TRACT UROTHELIAL CARCINOMA: MORPHOLOGY, DIAGNOSTICS AND TREATMENT. Medical Visualization. 2018;(1):78-92. (In Russ.) https://doi.org/10.24835/1607-0763-2018-1-78-92